BC
MRTX

Bridgefront Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bridgefront Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,139
Closed -$202K – 475
2021
Q3 		$202K Buy
+1,139
New +$202K 0.21% 246
2021
Q1 		– Sell
-3,739
Closed -$821K – 971
2020
Q4 		$821K Buy
+3,739
New +$821K 0.28% 91